Schedule 13D ownership disclosure

Nautilus Biotechnology, Inc.

Security class unavailable · CUSIP: 63909J108

Event date: 2023-02-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,947,732
Percent of class
15.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001808805-23-000016
Form type
SC 13D/A
Filer
Nautilus Biotechnology, Inc.
CIK
CIK 1808805
Filed
Mar 01, 2023
Reporting period
Feb 27, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub